Induction of neuronal death by microglial AGE-albumin: Implications for Alzheimer's disease

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Byun, Kyunghee ^a   Bayarsaikhan, Enkhjaigal ^a   Kim, Daesik ^a   Kim, Chae Young ^b   Mook Jung, Inhee ^b   Paek, Sun Ha ^b   Kim, Seung U ^c   Yamamoto, Tadashi ^d   Won, Moo Ho ^e   Song, Byoung Joon ^f   Park, Young Mok ^g   Lee, Bonghee ^a  

^a Gachon University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^e Kangwon National University   (South Korea)

^f NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^g Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALAGEBRIUM; ALBUMIN; AMYLOID BETA PROTEIN; PYRIDOXAMINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL ACTIVATION; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROGLIA; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; UPREGULATION;

ALBUMINS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BRAIN; CELL DEATH; CELL LINE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MICROGLIA; NEURONS; OXIDATIVE STRESS; PROTEIN MULTIMERIZATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC;

ANIMALIA; RATTUS;

EID: 84861466154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037917     Document Type: Article

References (32)

1. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D, (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J Neuroimmunol 24: 173-182.
2. Luber-Narod J, Rogers J, (1988) Immune system associated antigens expressed by cells of the human central nervous system. Neurosci Lett 94: 17-22.
3. McGeer PL, Itagaki S, Tago H, McGeer EG, (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79: 195-200.
4. Eikelenboom P, Rosemuller AJ, Hoozemans JI, Veerhuis R, van Gool WA, (2000) Neuroinflammation and Alzheimer's disease: Clinical and therapeutic implications. Alzheimer Dis Assoc Disord 14: S54-61.
5. Neuroinflammation Working Group (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421.
6. Ahn SM, Byun K, Kim D, Lee K, Yoo JS, et al. (2008) Human microglial cells synthesize albumin in brain. PLoS ONE 3: e2829.
7. Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, et al. (2008) Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32: 412-419.
8. Hickman SE, Allison EK, El Khoury J, (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28: 8354-8360.
9. Khoury EJ, Luster AD, (2008) Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol Sci 29: 626-632.
10. Perry VH, Nicoll JAR, Holmes C, (2010) Microglia in neurodegenerative disease. Nature Reviews Neurology 6: 193-201.
11. Schmidt AM, Yan SD, Yan SF, Stern DM, (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-955.
12. Schumacher U, Kretzschmar H, Pfüller U, (1994) Staining of cerebral amyloid plaque glycoproteins in patients with Alzheimer's disease with the microglia-specific lectin from mistletoe. Acta Neuropathol 87: 422-424.
13. Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, et al. (2001) Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging 22: 397-402.
14. Takeuchi M, Sato T, Takino J, Kobayashi Y, Furuno S, et al. (2007) Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease. Med Hypotheses 69: 1358-1366.
15. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, et al. (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517.
16. Yan SD, Fu J, Soto C, Chen X, Zhu H, et al. (1997) An intracellular protein that binds amyloid-betapeptide and mediates neurotoxicity in Alzheimer's disease. Nature 389: 689-695.
17. Gsell W, Strein I, Riederer PJ, (1996) The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared. Neural Transm (Suppl. 47): 73-101.
18. Münch G, Thome J, Foley P, Schinzel R, Riederer P, (1997) Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Brain Res Rev. 23 (1-2): 134-143.
19. Gsell W, Strein I, Krause U, Riederer PJ, (1997) Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease-a comparative review. Neural Transm (Suppl. 51): 145-59.
20. Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, et al. (1998) Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm. 105 (8-9): 1005-15.
21. Münch G, Schinzel R, Loske C, Wong A, Durany N, et al. (1998) Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm. 105 (4-5): 439-61.
22. Münch G, Westcott B, Menini T, Gugliucci A, (2012) Advanced glycation endproducts and their pathogenic roles in neurological disorders. Amino Acids. 42 (4): 1221-1236.
23. Rahmadi A, Steiner N, Münch G, (2011) Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease. Clin Chem Lab Med. 49 (3): 385-91.
24. Krautwald M, Leech D, Horne S, Steele ML, Forbes J, et al. (2011) The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase. Rejuvenation Res. 14 (4): 383-391.
25. Yan SD, Bierhaus A, Nawroth PP, Stern DM, (2009) RAGE and Alzheimer's Disease: A progression factor for amyloid-β-induced cellular perturbation? J Alz Dis 16: 833-843.
26. Hajnóczky G, Csordá G, Das S, Garcia-Perez C, Saotome M, et al. (2006) Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 40: 553-560.
27. Orrenius S, Zhivotovsky B, Nicotera P, (2003) Regulation of cell death: the calcium-apoptosis link. Nature Rev Mol Cell Biol 4: 552-565.
28. Kim BJ, Ryu SW, Song BJ, (2006) JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 281: 21256-21265.
29. Ko HW, Park KY, Kim H, Han PL, Kim YU, et al. (1998) Ca2+-mediated activation of c-Jun N-terminal kinase and nuclear factor κB by NMDA in cortical cell cultures. J Neurochem 71: 1390-1395.
30. LeBlanc AC, (1995) Increased production of 4 kDa amyloid β peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J. Neurosci. 15: 7837-7846.
31. Bohrmann B, Tjernberg L, Kuner P, Poli, S, Levet-Trafit B, et al. (1999) Endogenous proteins controlling amyloid β-peptide polymerization. Possible implications for β-amyloid formation in the central nervous system and in peripheral tissues. J Biol Chem 274: 15990-15995.
32. Stine WB, Dahlgren KN, Krafft GA, LaDu MJ, (2003) In vitro characterization of conditions for amyloid-peptide oligomerization and fibrillogenesis. J Biol Chem 278 (13): 11612-11622.